Category

• Business1
• Pipeline1

Organizations

• Bausch + Lomb64
• Eyes On Eyecare42
• Alcon, Inc.41
• American Optometric Association34
• Harrow26
• Glaukos25
• Regeneron21
• Aldeyra Therapeutics20
• Sight Sciences19
• American Academy Of Ophthalmology18

Tags

• Cornea2
• Clinical Trials1
• Corneal Dystrophy1
• Finance1
• Research1
• Technology1

• Organizations: Brightstar Therapeutics✕

Clear all

Pipeline

New findings support Brightstar Therapeutics' corneal allograft for LSCD

Pilot study investigates use of BrightMEM as an alternative form of corneal transplantation involving Descemet’s membrane.

Business

Brightstar Therapeutics secures financing for groundbreaking corneal disease treatment

Company plans to launch trials on its BrightMEM corneal allograft; appoints two new ophthalmologists to leadership positions.